Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management (Companion Faculty Lecture)
Research To Practice | Oncology Videos
00:00
Second‑Line Options and Their Limitations
Strosberg covers re‑challenging platinum, common second‑line regimens, and generally poor outcomes in prospective studies.
Play episode from 12:06
Transcript
